Lumexa Imaging Holdings, Inc. LMRI
11.22 USD +0.07 (+0.63%)
At closeNov 3, 2026, 4:55 PM EST
11.22 0.00 0.00%
After hours · Nov 3, 4:55 PM ET
11.03 Day range 11.27
6.45 52-week range 19.45
- YTD
- -39.35%
- 1 year
- -39.42%
Analyst view
Price target (mean) 17.67 +57.5% upside
Now 11.22
- Target (low)
- 13.00
- Target (mean)
- 17.67
- Target (high)
- 23.00
Ratings (0m) 10 10 buy · 0 hold · 0 sell
- Strong buy2
- Buy8
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 9
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.18196 | 0.16 – 0.22 | 0.00 | 0.0% | 269.89M | 0.0% | 8 |
| Next quarter | 0.20818 | 0.19 – 0.24 | 0.0111 | +1775.5% | 280.08M | +4.6% | 8 |
| Current year | 0.76594 | 0.72748 – 0.84 | 0.1796 | +326.5% | 1.07B | +4.3% | 8 |
| Next year | 0.89013 | 0.80 – 1.00 | 0.76594 | +16.2% | 1.12B | +5.4% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | Truist Securities | Initiated | — | Buy |
| Sep 25, 2026 | Keybanc | Initiated | — | Overweight |
| Aug 28, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 20, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 9, 2026 | Raymond James | Upgrade | Outperform | Strong Buy |
| Jan 5, 2026 | Raymond James | Initiated | — | Outperform |
| Jan 5, 2026 | Barclays | Initiated | — | Overweight |
| Jan 5, 2026 | Wells Fargo | Initiated | — | Overweight |
| Jan 5, 2026 | William Blair | Initiated | — | Outperform |
| Jan 5, 2026 | Deutsche Bank | Initiated | — | Buy |
| Jan 5, 2026 | Leerink Partners | Initiated | — | Outperform |
| Jan 5, 2026 | Jefferies | Initiated | — | Buy |